Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings
Shares of Elite Pharmaceuticals, Inc. ELTP have lost 13.7% since the company reported earnings for the fiscal year ended March 31, 2026, underperforming the S&P 500 Index, which gained 1.8% over the same period. The stock has also trailed the broader market over the past …